Literature DB >> 10738889

Osseous lesions of the distal ulna: atypical location--unusual diagnosis. Report of three cases with similar imaging and different pathologic diagnoses.

G U Exner1, A R von Hochstetter, H Honegger, A Schreiber.   

Abstract

Three cases with destructive bone lesions of the distal end of the ulna caused by different pathologic entities (Ewing's sarcoma, osteosarcoma, rheumatoid pseudotumoral synovitis) are presented, all with similar clinical and comparable x-ray and magnetic resonance imaging features. Although the distal end of the ulna may be resected without significant functional impairment, careful evaluation of treatment strategies compatible with oncologic standards is warranted.

Entities:  

Mesh:

Year:  2000        PMID: 10738889     DOI: 10.1007/s004020050049

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  4 in total

1.  Extensor Carpi Ulnaris Tenodesis Versus No Stabilization After Wide Resection of Distal Ulna Giant Cell Tumors.

Authors:  Ioannis D Papanastassiou; Olga D Savvidou; George D Chloros; Panayiotis D Megaloikonomos; Vasileios A Kontogeorgakos; Panayiotis J Papagelopoulos
Journal:  Hand (N Y)       Date:  2017-11-28

2.  Fibroblastic type osteosarcoma of the ulna: a case report of a tumor in a rare location with atypical imaging findings.

Authors:  Ijin Joo; Jung Ah Choi; Jin Haeng Chung; Joo Han Oh; Sung Hwan Hong; Heung Sik Kang
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

3.  A case of parosteal osteosarcoma with a rare complication of myositis ossificans.

Authors:  Maria Silvia Spinelli; Carlo Perisano; Carlo Della Rocca; Jendrick Hardes; Carlo Barone; Carlo Fabbriciani; Giulio Maccauro
Journal:  World J Surg Oncol       Date:  2012-11-29       Impact factor: 2.754

4.  Primary bone tumors and tumor like lesions of the ulna.

Authors:  Osman Emre Aycan; Sami Sökücü; Devrim Özer; Engin Çetinkaya; Yavuz Arıkan; Yavuz Selim Kabukçuoğlu
Journal:  Acta Orthop Traumatol Turc       Date:  2018-11-12       Impact factor: 1.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.